Verrica Pharmaceuticals Inc. is a biotechnology firm based in West Chester, Pennsylvania, dedicated to developing and commercializing innovative dermatological therapies for unmet medical needs. The company specializes in proprietary formulations and advanced delivery systems, targeting conditions such as common warts and superficial skin lesions. With a strong focus on enhancing patient outcomes and leveraging its expertise in dermatology, Verrica is well-positioned to establish itself as a key player in the dermatology market, driving advancements in skin health and improving overall patient quality of life. Show more
Location: 44 WEST GAY STREET, WEST CHESTER, PA, UNITED STATES, 19380, West Chester, PA, 19380, USA | Website: https://www.verrica.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
112.4M
52 Wk Range
$3.28 - $9.82
Previous Close
$7.03
Open
$7.40
Volume
257,475
Day Range
$7.25 - $7.84
Enterprise Value
81.35M
Cash
21.1M
Avg Qtr Burn
N/A
Insider Ownership
51.84%
Institutional Own.
19.11%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
YCANTH (VP-102) Details Infectious disease, Molluscum contagiosum | Approved Quarterly sales | |
YCANTH (VP-102) Details Common warts | Phase 3 Update | |
VP-315 Details Basal cell carcinoma | Phase 2 Update |
